Compare GLDD & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GLDD | INMD |
|---|---|---|
| Founded | 1890 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 879.2M |
| IPO Year | 2007 | 2018 |
| Metric | GLDD | INMD |
|---|---|---|
| Price | $16.95 | $13.57 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 6 |
| Target Price | ★ $20.00 | $16.75 |
| AVG Volume (30 Days) | ★ 2.0M | 1.2M |
| Earning Date | 05-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.57 | N/A |
| EPS | ★ 1.08 | N/A |
| Revenue | ★ $702,503,000.00 | N/A |
| Revenue This Year | $2.50 | $3.80 |
| Revenue Next Year | $9.83 | $4.79 |
| P/E Ratio | $15.69 | ★ $10.11 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.51 | $13.16 |
| 52 Week High | $16.99 | $19.78 |
| Indicator | GLDD | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 69.70 | 38.67 |
| Support Level | $10.81 | N/A |
| Resistance Level | $16.99 | $15.02 |
| Average True Range (ATR) | 0.10 | 0.40 |
| MACD | -0.06 | -0.13 |
| Stochastic Oscillator | 94.50 | 15.55 |
Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company is also fully engaged in expanding its core business into the offshore energy industry. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Company work generally is to performed in coastal waterways and deep water ports. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.